Angelini Pharma UK-I
  • Global Site
  • Angelini Pharma

  • Who we are

    • Angelini Pharma in UK & Ireland
    • Angelini Pharma

  • Core areas

    • Epilepsy
  • Products

  • Our Responsibility

    • Transparency
    • Diversity & Inclusion
    • Ethics
    • Collaborative Working
  • Contact
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Site map

Site map

  1. Who we are
    • Angelini Pharma in UK & Ireland
    • Angelini Pharma
  2. Core areas
    • Epilepsy
  3. Products
  4. Our Responsibility
    • Transparency
    • Diversity & Inclusion
    • Ethics
    • Collaborative Working
  5. Contact
  6. Terms and conditions of use
  7. Privacy
  8. Cookie Policy
Torna indietro
  • Top Employer Europe 2025
  • Terms and conditions of use
  • Privacy
  • Cookie Policy
  • Site map
  • Contact

Angelini Pharma UK & Ireland
6th floor, Napier House, 24 High Holborn, WC1V 6AZ London, United Kingdom
E-mail: info.uk@angelinipharma.com
Company number: 13473950
VAT number: GB387249551
Job code: UK2226NP, Date of preparation May 2024

â–¼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card System at www.MHRA.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. By reporting side effects you can help provide more information on the safety of this medicine. If you are a patient or healthcare professional and need to report an adverse event or have a product complaint, please contact Angelini Pharma on (UK) UKIReporting@angelinipharma.com
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Close menu

You are now leaving AngeliniPharma.co.uk.

Angelini Pharma UK-I is not responsible for information outside this website.